Resverlogix Inc

Call
Website
44 Montgomery St Ste 4010
San Francisco, CA 94104
+1 (415) 470-5600
https://www.resverlogix.com

Resverlogix Inc is a late-stage clinical biotechnology company based in San Francisco, CA. Founded in 2001, the company focuses on developing safe and effective therapeutics for patients suffering from chronic illnesses. With a strong emphasis on epigenetics, Resverlogix is a global leader in the development of a new class of drugs designed to regulate disease-associated epigenetics, particularly in cardiovascular diseases.

Resverlogix's flagship drug, apabetalone, has received Breakthrough Therapy designation from the US FDA, positioning the company at the forefront of modern medicine. Through their science programs and global Phase 3 clinical trial, BETonMACE, Resverlogix aims to provide innovative solutions to key stakeholders, including payer groups, and improve the lives of patients with high unmet medical needs.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Biotechnical research, noncommercial

Mandalmed, Inc

MandalMed, Inc. is a San Francisco-based company specializing in research and development in the field of medicine. With a focus on intellectual property, they are dedicated to advancing innovative solutions for healthcare. Driven by a team of experts, MandalMed is committed to pushing the boundaries of medical technology and improving patient outcomes. Their cutting-edge research and development efforts position them at the forefront of the industry, making them a key player in the future of healthcare.Generated from the website
Abbott Diabetes Care Inc
Business services, nec, nec, Diabetes specialist, physician/surgeon, Biotechnical research, noncommercial

Abbott Diabetes Care Inc

Abbott Diabetes Care, located in Alameda, Calif., designs, develops and manufactures several glucose monitoring systems and test strips for use in both home and hospital settings. Among its brands are FreeStyle, FreeStyle Flash, Precision Xtra and Precision PCx. Abbott entered the blood glucose monitoring marketplace with the acquisition of MediSense in 1996. In 2004, the company acquired TheraSense, a leader in developing blood glucose self-monitoring devices that require very small blood samples to deliver rapid test results. ADC is a subsidiary of Abbott Laboratories, a global health care company devoted to the discovery of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.
Biotechnical research, noncommercial, Business services, nec, nec, Blood derivatives

Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that specializes in the discovery, development, and commercialization of innovative medicines. The company's primary focus is on advancing healthcare through cutting-edge research and the creation of groundbreaking pharmaceutical solutions. Generated from their website's infomation
United States›California›San Francisco›Resverlogix Inc

Partial Data by Infogroup (c) 2025. All rights reserved.